UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000022200
Receipt No. R000025574
Official scientific title of the study Impact of lubiprostone on gastric emptying in healthy volunteer
Date of disclosure of the study information 2016/05/06
Last modified on 2018/11/05 (Ver. 2)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Impact of lubiprostone on gastric emptying in healthy volunteer
Title of the study (Brief title) Impact of lubiprostone on gastric emptying in healthy volunteer
Region
Japan

Condition
Condition gastric emptying
Classification by specialty
Adult
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To examine the impact of lubiprostone on gastric emptying in healthy volunteers.
Basic objectives2 Pharmacokinetics
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Change of gastric emptying parameters after administration of lubiprostone
Key secondary outcomes Gastrointestinal symptom

Base
Study type Interventional

Study design
Basic design Cross-over
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Placebo
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 3
Purpose of intervention Treatment
Type of intervention
Medicine
Interventions/Control_1 single dose of lubiprostone 24 microgram 1 tablet
Interventions/Control_2 single dose of lubiprostone 24 microgram 1 tablet and domperidone 10 mirigram 1 tablet
Interventions/Control_3 no medication
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
50 years-old >=
Gender Male
Key inclusion criteria who has neither gastrointestinal symptoms, medications taken regularly, nor past history of abdominal surgery.
Key exclusion criteria who does not match the above condition.
Target sample size 10

Research contact person
Name of lead principal investigator Takatsugu Yamamoto
Organization Teikyo University
Division name Internal Medicine
Address 2-11-1, Kaga, Itabashi-ku, Tokyo
TEL 03-3964-1211
Email ymmt@med.teikyo-u.ac.jp

Public contact
Name of contact person Takatsugu Yamamoto
Organization Teikyo University
Division name Internal Medicine
Address 2-11-1, Kaga, Itabashi-ku, Tokyo
TEL 03-3964-1211
Homepage URL
Email ymmt@med.teikyo-u.ac.jp

Sponsor
Institute Teikyo University
Institute
Department

Funding Source
Organization self funding
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2016 Year 05 Month 06 Day

Progress
Recruitment status Completed
Date of protocol fixation
2016 Year 02 Month 12 Day
Anticipated trial start date
2016 Year 04 Month 01 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Published
URL releasing results
Results
Other related information

Management information
Registered date
2016 Year 05 Month 04 Day
Last modified on
2018 Year 11 Month 05 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000025574